Urologische Klinik und Poliklinik » Forschung » Publikationen 2011

Publikationen 2011

[Thrombectomy in kidney tumors].
Aktuelle Urol. 2011;42(1): 59-72; quiz 73-4
Bachmann A, Subotic S, Stief CG

Human renal cell carcinoma induces a dendritic cell subset that uses T-cell crosstalk for tumor-permissive milieu alterations.
Am J Pathol. 2011;179(1): 436-51
Figel AM, Brech D, Prinz PU, Lettenmeyer UK, Eckl J, Turqueti-Neves A, Mysliwietz J, Anz D, Rieth N, Muenchmeier N, Buchner A, Porubsky S, Siegert SI, Segerer S, Nelson PJ, Noessner E

Evaluation of a new prognostic score (Munich score) to predict long-term survival after resection of pulmonary renal cell carcinoma metastases.
Am J Surg. 2011;202(2): 158-67
Meimarakis G, Angele M, Staehler M, Clevert DA, Crispin A, Rüttinger D, Löhe F, Preissler G, Hatz RA, Winter H

Systemic and cavernous plasma levels of neuropeptide Y during sexual arousal in healthy males.
Andrologia. 2011; [Epub ahead of print]
Uckert
S, Soyk L, Trottmann M, Stief CG, Kuczyk MA, Becker AJ

Is there a significance of histamine in the control of the human male sexual response?
Andrologia. 2011; [Epub ahead of print]
Uckert S, Wilken M, Stief C, Trottmann M, Kuczyk M, Becker A

Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settings.
Ann Oncol. 2011; [Epub ahead of print]
Beck J, Procopio G, Bajetta E, Keilholz U, Negrier S, Szczylik C, Bokemeyer C, Bracarda S, Richel DJ, Staehler M, Strauss UP, Mersmann S, Burock K, Escudier B

Outcome of treatment discontinuation in patients with metastatic renal cell carcinoma and no evidence of disease following targeted therapy with or without metastasectomy.
Ann Oncol. 2011;22(3): 657-63
Johannsen M, Staehler M, Ohlmann CH, Flörcken A, Schmittel A, Otto T, Bex A, Hein P, Miller K, Weikert S, Grünwald V

Association Between the Number of Dissected Lymph Nodes During Pelvic Lymphadenectomy and Cancer-Specific Survival in Patients with Lymph Node-Negative Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy.
Ann Surg Oncol. 2011; [Epub ahead of print]
May M, Herrmann E, Bolenz C, Brookman-May S, Tiemann A, Moritz R, Fritsche HM, Burger M, Trojan L, Michel MS, Wülfing C, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Bastian PJ

Vascular Wall as a Reservoir for Different Types of Stem and Progenitor Cells.
Antioxid Redox Signal. 2011; [Epub ahead of print]
Ergün S, Tilki D, Klein D

DNA hypermethylation in papillary renal cell carcinoma.
BJU Int. 2011;107(4): 664-9
Ellinger J, Holl D, Nuhn P, Kahl P, Haseke N, Staehler M, Siegert S, Hauser S, Stief CG, Müller SC, Bastian PJ

Critical review of lasers in benign prostatic hyperplasia (BPH).
BJU Int. 2011;107(7): 1030-43
Gravas S, Bachmann A, Reich O, Roehrborn CG, Gilling PJ, De La Rosette J

Alpha1-adrenoceptor activation induces phosphorylation of ?2-adrenoceptors in human prostate tissue.
BJU Int. 2011; [Epub ahead of print]
Hennenberg M, Strittmatter F, Walther S, Hedlund P, Andersson KE, Stief CG, Gratzke C, Schlenker B

Real-time magnetic resonance imaging (MRI): anatomical changes during physiological voiding in men.
BJU Int. 2011; [Epub ahead of print]
Hocaoglu Y, Roosen A, Herrmann K, Tritschler S, Stief C, Bauer RM

Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study.
BJU Int. 2011; [Epub ahead of print]
Matsumoto K, Novara G, Gupta A, Margulis V, Walton TJ, Roscigno M, Ng C, Kikuchi E, Zigeuner R, Kassouf W, Fritsche HM, Ficarra V, Martignoni G, Tritschler S, Rodriguez JC, Seitz C, Weizer A, Remzi M, Raman JD, Bolenz C, Bensalah K, Koppie TM, Karakiewicz PI, Wood CG, Montorsi F, Iwamura M, Shariat SF

Multicenter evaluation of the prognostic value of pT0 stage after radical cystectomy due to urothelial carcinoma of the bladder.
BJU Int. 2011; [Epub ahead of print]
May M, Bastian PJ, Burger M, Bolenz C, Trojan L, Herrmann E, Wülfing C, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Otto W, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Wieland WF, Fritsche HM

Global histone H4K20 trimethylation predicts cancer-specific survival in patients with muscle-invasive bladder cancer.
BJU Int. 2011; [Epub ahead of print]
Schneider AC, Heukamp LC, Rogenhofer S, Fechner G, Bastian PJ, von Ruecker A, Müller SC, Ellinger J

Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort.
BJU Int. 2011;107(6): 898-904
Svatek RS, Shariat SF, Novara G, Skinner EC, Fradet Y, Bastian PJ, Kamat AM, Kassouf W, Karakiewicz PI, Fritsche HM, Izawa JI, Tilki D, Ficarra V, Volkmer BG, Isbarn H, Dinney CP

Mid-term results for the retroluminar transobturator sling suspension for stress urinary incontinence after prostatectomy.
BJU Int. 2011;108(1): 94-8
Bauer RM, Soljanik I, Füllhase C, Karl A, Becker A, Stief CG, Gozzi C

Volar onlay urethroplasty for reconstruction of female urethra in recurrent stricture disease.
BJU Int. 2011;107(12): 1964-6
Gozzi C, Roosen A, Bastian PJ, Karl A, Stief C, Tritschler S

Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy.
BJU Int. 2011;108(5): 687-92
Sonpavde G, Khan MM, Svatek RS, Lee R, Novara G, Tilki D, Lerner SP, Amiel GE, Skinner E, Karakiewicz PI, Bastian PJ, Kassouf W, Fritsche HM, Izawa JI, Ficarra V, Dinney CP, Lotan Y, Fradet Y, Shariat SF

Simultaneous anti-angiogenic therapy and single-fraction radiosurgery in clinically relevant metastases from renal cell carcinoma.
BJU Int. 2011;108(5): 673-8
Staehler M, Haseke N, Nuhn P, Tüllmann C, Karl A, Siebels M, Stief CG, Wowra B, Muacevic A

Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort.
BJU Int. 2011;108(3): 406-12
Walton TJ, Novara G, Matsumoto K, Kassouf W, Fritsche HM, Artibani W, Bastian PJ, Martínez-Salamanca JI, Seitz C, Thomas SA, Ficarra V, Burger M, Tritschler S, Karakiewicz PI, Shariat SF

Global histone H3K27 methylation levels are different in localized and metastatic prostate cancer.
Cancer Invest. 2011;30(2): 92-7
Ellinger J, Kahl P, von der Gathen J, Heukamp LC, Gütgemann I, Walter B, Hofstädter F, Bastian PJ, von Ruecker A, Müller SC, Rogenhofer S

Individual Learning Curve Reduces the Clinical Value of Urinary Cytology.
Clin Genitourin Cancer. 2011; [Epub ahead of print]
Strittmatter F, Buchner A, Karl A, Sommer ML, Straub J, Tilki D, Hennenberg M, Knuechel R, Stief CG, Zaak D, Tritschler S

Acoustic radiation force impulse imaging of the testes: a preliminary experience.
Clin Hemorheol Microcirc. 2011;49(1-4): 105-14
D'Anastasi M, Schneevoigt BS, Trottmann M, Crispin A, Stief C, Reiser MF, Clevert DA

Greenlight: from potassium-titanyl-phosphate to lithium triborate or from good to better?
Curr Opin Urol. 2011;21(1): 27-30
Reich O

[Bladder catheterization].
DtschMed Wochenschr. 2011;136(4): 145-7
Schneevoigt
BS, Stief C

Management of pelvic lymphoceles after radical prostatectomy: a multicentre community based study.
Eur J Med Res. 2011;16(6): 280-4
Khoder WY, Trottmann M, Seitz M, Buchner A, Stuber A, Hoffmann S, Stief CG, Becker AJ

Malnutrition and clinical outcome in urological patients.
Eur J Med Res. 2011;16(10): 469-72
Karl A, Staehler M, Bauer R, Tritschler S, Hocaoglu Y, Buchner A, Hoffmann J, Kuppinger D, Stief C, Rittler P

Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage?
Eur J Med Res. 2011;16(10): 445-50
Strittmatter F, Stieber P, Nagel D, Füllhase C, Walther S, Stief CG, Waidelich R

Thromboxane A2 induces contraction of human prostate smooth muscle by Rho kinase- and calmodulin-dependent mechanisms.
Eur J Pharmacol. 2011;650(2-3): 650-5
Strittmatter F, Gratzke C, Weinhold P, Steib CJ, Hartmann AC, Schlenker B, Andersson KE, Hedlund P, Stief CG, HennenbergM

Delineation of upper urinary tract segments at MDCT urography in patients with extra-urinary mass lesions: retrospective comparison of standard and low-dose protocols for the excretory phase of imaging.
Eur Radiol. 2011;21(2): 378-84
Mueller-Lisse
UL, Coppenrath EM, Meindl T, Degenhart C, Scherr MK, Stief CG, Reiser MF, Mueller-Lisse UG

Does the Extent of Lymphadenectomy in Radical Cystectomy for Bladder Cancer Influence Disease-Free Survival? A Prospective Single-Center Study.
Eur Urol. 2011;  [Epub ahead of print]
Abol-Enein H, Tilki D, Mosbah A, El-Baz M, Shokeir A, Nabeeh A, Ghoneim MA

Long-term follow-up of bladder cancer patients with disseminated tumour cells in bone marrow.
Eur Urol. 2011;60(2): 231-8
Retz M, Rotering J, Nawroth R, Buchner A, Stöckle M, Gschwend JE, Lehmann J

The role of antimuscarinics in the management of men with symptoms of overactive bladder associated with concomitant bladder outlet obstruction: an update.
Eur Urol. 2011;60(1): 94-105
Athanasopoulos A, Chapple C, Fowler C, Gratzke C, Kaplan S, Stief C, Tubaro A

The "all-seeing needle": initial results of an optical puncture system confirming access in percutaneous nephrolithotomy.
Eur Urol. 2011;59(6): 1054-9
Bader MJ, Gratzke C, Seitz M, Sharma R, Stief CG, Desai M

Does the surgeon really matter? Functional results following radical prostatectomy.
Eur Urol. 2011;59(3): 323-4
Bastian PJ

Contemporary management of postprostatectomy incontinence.
Eur Urol. 2011;59(6): 985-96
Bauer RM, Gozzi C, Hübner W, Nitti VW, Novara G, Peterson A, Sandhu JS, Stief CG

Reply to Jin-Yi Li, Zilian Cui, Xiao Feng Gao, et al's Letter to the Editor re: Markus J. Bader, Christian Gratzke, Michael Seitz, et al. The "All-Seeing Needle": Initial Results of an Optical Puncture System Confirming Access in Percutaneous Nephrolithot
Eur Urol. 2011;  [Epub ahead of print]
Desai M, Gratzke C, Seitz M, Sharma R, Stief CG, Bader MJ

Toxicities of targeted therapy and their management in kidney cancer.
Eur Urol. 2011;59(4): 526-40
Di Lorenzo G, Porta C, Bellmunt J, Sternberg C, Kirkali Z, Staehler M, Joniau S, Montorsi F, Buonerba C

Epigenetics in Prostate Cancer: Biologic and Clinical Relevance.
Eur Urol. 2011; [Epub ahead of print]
Jerónimo C, Bastian PJ, Bjartell A, Carbone GM, Catto JW, Clark SJ, Henrique R, Nelson WG, Shariat SF

Phosphodiesterase Type 5 Inhibitors in the Management of Non-neurogenic Male Lower Urinary Tract Symptoms: Critical Analysis of Current Evidence.
Eur Urol. 2011; [Epub ahead of print]
Martínez-Salamanca JI, Carballido J, Eardley I, Giuliano F, Gratzke C, Rosen R, Salonia A, Stief C

Lymph Node Density Affects Cancer-Specific Survival in Patients with Lymph Node-Positive Urothelial Bladder Cancer Following Radical Cystectomy.
Eur Urol. 2011; [Epub ahead of print]
May M, Herrmann E, Bolenz C, Tiemann A, Brookman-May S, Fritsche HM, Burger M, Buchner A, Gratzke C, Wülfing C, Trojan L, Ellinger J, Tilki D, Gilfrich C, Höfner T, Roigas J, Zacharias M, Gunia S, Wieland WF, Hohenfellner M, Michel MS, Haferkamp A, Müller SC, Stief CG, Bastian PJ

External Validation of Postoperative Nomograms for Prediction of All-Cause Mortality, Cancer-Specific Mortality, and Recurrence in Patients With Urothelial Carcinoma of the Bladder.
Eur Urol. 2011; [Epub ahead of print]
Nuhn P, May M, Sun M, Fritsche HM, Brookman-May S, Buchner A, Bolenz C, Moritz R, Herrmann E, Burger M, Tilki D, Trojan L, Perrotte P, Haferkamp A, Hohenfellner M, Wieland WF, Müller SC, Karakiewicz PI, Bastian PJ

Using laser to unobstruct the obstructed prostatic urethra due to benign prostatic hyperplasia: has transurethral resection of the prostate finally become history, or is it here to stay?
Eur Urol. 2011;60(4): 740-1
Stief CG

If a partial nephrectomy could be done safely for a renal tumor, would radical nephrectomy be considered malpractice?
Eur Urol. 2011;60(3): 465-6
Stief CG

Urine Markers for Detection and Surveillance of Non-Muscle-Invasive Bladder Cancer.
Eur Urol. 2011; [Epub ahead of print]
Tilki D, Burger M, Dalbagni G, Grossman HB, Hakenberg OW, Palou J, Reich O, Rouprêt M, Shariat SF, Zlotta AR

Contemporary Management of Small Renal Masses.
Eur Urol. 2011; [Epub ahead of print]
Volpe A, Cadeddu JA, Cestari A, Gill IS, Jewett MA, Joniau S, Kirkali Z, Marberger M, Patard JJ, Staehler M, Uzzo RG

Treatment of erectile dysfunction and lower urinary tract symptoms by phosphodiesterase inhibitors.
HandbExp Pharmacol. 2011;(204): 307-22
Uckert
S, Stief CG

Serum endostatin levels correlate with enhanced extracellular matrix degradation and poor patients' prognosis in bladder cancer.
Int J Cancer. 2011; [Epub ahead of print]
Szarvas T, László V, Dorp FV, Reis H, Szendr?i A, Romics I, Tilki D, Rübben H, Ergün S

Risk factors for pelvic lymphoceles post-radical prostatectomy.
Int J Urol. 2011; [Epub ahead of print]
Khoder WY, Trottmann M, Buchner A, Stuber A, Hoffmann S, Stief CG, Becker AJ

Impact of collateral damage to endourologic tools during laser lithotripsy--in vitro comparison of three different clinical laser systems.
J Endourol. 2011;25(4): 667-72
Bader MJ, Gratzke C, Hecht V, Schlenker B, Seitz M, Reich O, Stief CG, Sroka R

Water-Jet-Aided Transurethral Dissection of Urothelial Carcinoma: A Prospective Clinical Study.
J Endourol. 2011; [Epub ahead of print]
Fritsche HM, Otto W, Eder F, Hofstädter F, Denzinger S, Chaussy CG, Stief C, Wieland WF, Burger M

Modified laparoscopic lymphocele marsupialization for the treatment of lymphoceles after radical prostatectomy: first results.
J Laparoendosc Adv Surg Tech A. 2011;21(2): 145-8
Khoder WY, Becker AJ, Seitz M, Haseke N, Schlenker B, Stief CG

Transcript signature predicts tissue NK cell content and defines renal cell carcinoma subgroups independent of TNM staging.
J Mol Med. 2011; [Epub ahead of print]
Eckl J, Buchner A, Prinz PU, Riesenberg R, Siegert SI, Kammerer R, Nelson PJ, Noessner E

Electrical activity of corpus cavernosum during flaccidity and erection of the human penis: a new diagnostic method? Wagner G, Gerstenberg T, and Levin RJ.
J Sex Med. 2011;8(10): 2678-80
Glina S, Bertero E, Stief CG

Single-step percutaneous nephrolithotomy (microperc): the initial clinical report.
J Urol. 2011;186(1): 140-5
Desai MR, Sharma R, Mishra S, Sabnis RB, Stief C, Bader M

Cannabinor, a selective cannabinoid-2 receptor agonist, improves bladder emptying in rats with partial urethral obstruction.
J Urol. 2011;185(2): 731-6
Gratzke C, Streng T, Stief CG, Alroy I, Limberg BJ, Downs TR, Rosenbaum JS, Hedlund P, Andersson KE

Cannabinor, a selective cannabinoid-2 receptor agonist, improves bladder emptying in rats with partial urethral obstruction.
J Urol. 2011;185(2): 731-6
Gratzke C, Streng T, Stief CG, Alroy I, Limberg BJ, Downs TR, Rosenbaum JS, Hedlund P, Andersson KE

Prognostic risk stratification of pathological stage T3N0 bladder cancer after radical cystectomy.
J Urol. 2011;185(4): 1216-21
Sonpavde G, Khan MM, Svatek RS, Lee R, Novara G, Tilki D, Lerner SP, Amiel GE, Skinner E, Karakiewicz PI, Bastian PJ, Kassouf W, Fritsche HM, Izawa JI, Scherr DS, Ficarra V, Dinney CP, Lotan Y, Fradet Y, Shariat SF

Disease-free survival at 2 or 3 years correlates with 5-year overall survival of patients undergoing radical cystectomy for muscle invasive bladder cancer.
J Urol. 2011;185(2): 456-61
Sonpavde G, Khan MM, Lerner SP, Svatek RS, Novara G, Karakiewicz PI, Skinner E, Tilki D, Kassouf W, Fradet Y, Dinney CP, Fritsche HM, Izawa JI, Bastian PJ, Ficarra V, Schoenberg M, Sagalowsky AI, Lotan Y, Shariat SF

The 1,318-nm diode laser supported partial nephrectomy in laparoscopic and open surgery: preliminary results of a prospective feasibility study.
Lasers Med Sci. 2011;  [Epub ahead of print]
Khoder WY, Sroka R, Hennig G, Seitz M, Siegert S, Zillinberg K, Gratzke C, Stief CG, Becker AJ

[Female urinary incontinence affects all age groups. Well-tried and innovative treatment].
MMW Fortschr Med. 2011;153(20): 32
Bauer RM, Stief CG

[Surgical treatment for female stress urinary incontinence].
MMW Fortschr Med. 2011;153(20): 40-1
Bauer RM, Füllhase C, Gratzke C, Roosen A, Stief CG, Friese K, Dannecker C

[Diagnostics for female incontinence: two-stage assessment].
MMW Fortschr Med. 2011;153(20): 35-6
Bauer RM, Dannecker C, Füllhase
C, Roosen A, Stief CG, Friese K, Gratzke C

[Epidemiology and aetiology of female urinary incontinence].
MMW Fortschr Med. 2011;153(20): 33-4
Füllhase C, Dannecker C, Gratzke C, Stief CG, Friese K, Bauer RM

[Non-surgical treatment of female incontinence].
MMW Fortschr Med. 2011;153(20): 37-9
Füllhase
C, Gratzke C, Dannecker C, Stief CG, Friese K, Bauer RM

[Acute scrotal pain].
MMW Fortschr Med. 2011;153(8): 38-41; quiz 42
Schneevoigt BS, Karl A, Stief C

[Bladder cancer--symptoms and diagnosis].
MMW Fortschr Med. 2011;153(32-34): 38-41; quiz 42
Karl A, Tritschler S, Staehler M, Schneevoigt BS, Stief C

The role of metastasectomy in metastatic renal cell carcinoma.
Nat Rev Urol. 2011;8(4): 180-1
Staehler M

Rodent models for urodynamic investigation.
Neurourol Urodyn. 2011;30(5): 636-46
Andersson KE, Soler R, Füllhase C

Beta3-adrenoceptors in the rat sacral spinal cord and their functional relevance in micturition under normal conditions and in a model of partial urethral obstruction.
Neurourol Urodyn. 2011; [Epub ahead of print]
Füllhase C, Soler R, Westerling-Andersson K, Andersson KE

Vascular therapy for radiation cystitis.
Neurourol Urodyn. 2011;30(3): 428-34
Soler R, Vianello A, Füllhase C, Wang Z, Atala A, Soker S, Yoo JJ, Koudywilliam J

Development of bladder dysfunction in a rat model of dopaminergic brain lesion.
Neurourol Urodyn. 2011;30(1): 188-93
Soler R, Füllhase C, Santos C, Andersson KE

Induction of immune mediators in glioma and prostate cancer cells by non-lethal photodynamic therapy.
PLoS ONE. 2011;6(6): e21834
Kammerer R, Buchner A, Palluch P, Pongratz T, Oboukhovskij K, Beyer W, Johansson A, Stepp H, Baumgartner R, Zimmermann W

[CT urography in women with primary or recurrent pelvic tumors : background and initial experiences].
Radiologe. 2011;51(7): 602-9
Seifert S, Mueller-Lisse UG, Degenhart C, Jundt K, Mourched F, Stief CG, Reiser MF, Mueller-Lisse UL

Pathological upstaging detected in radical cystectomy procedures is associated with a significantly worse tumour-specific survival rate for patients with clinical T1 urothelial carcinoma of the urinary bladder.
Scand J Urol Nephrol. 2011; [Epub ahead of print]
May M, Bastian PJ, Brookman-May S, Burger M, Bolenz C, Trojan L, Michel MS, Herrmann E, Wülfing C, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Gunia S, Fritsche HM

Single-Incision Laparoscopic Surgery (SILS) in Reconstructive Urological Cases.
Surg Technol Int. 2011 Dec 1;XXI:35-40. [Epub ahead of print]
Khoder WY, Schlenker B, Trottmann M, Stief CG, Becker AJ

Patient-reported side effects of intradetrusor botulinum toxin type a for idiopathic overactive bladder syndrome.
Urol Int. 2011;86(1): 68-72
Bauer RM, Gratzke C, Roosen A, Hocaoglu Y, Mayer ME, Buchner A, Stief CG, May F

Coupling of ?(1)-Adrenoceptors to ERK1/2 in the Human Prostate.
Urol Int. 2011;86(4): 427-33
Bauer RM, Strittmatter F, Gratzke C, Göttinger J, Schlenker B, Reich O, Stief CG, Hedlund
P, Andersson KE, Hennenberg M

Concomitant Carcinoma in situ in Cystectomy Specimens Is Not Associated with Clinical Outcomes after Surgery.
Urol Int. 2011; [Epub ahead of print]
Nuhn P, Bastian PJ, Novara G, Svatek RS, Karakiewicz PI, Skinner E, Fradet Y, Izawa JI, Kassouf W, Montorsi F, Müller SC, Fritsche HM, Sonpavde G, Tilki D, Isbarn H, Ficarra V, Dinney CP, Shariat SF

Real-time MRI of continent and stress incontinent male patients after orthotopic ileal neobladder.
Urol Int. 2011;87(3): 325-9
Bauer RM, Herrmann K, Karl A, Stief CG, Hocaoglu Y

Course of size and density of metastatic renal cell carcinoma lesions in the early follow-up of molecular targeted therapy.
Urol Oncol. 2011; [Epub ahead of print]
Hittinger M, Staehler M, Schramm N, U?bleis C, Becker C, Reiser M, Berger F

Early incontinence after radical prostatectomy: A community based retrospective analysis in 911 men and implications for preoperative counseling.
Urol Oncol. 2011; [Epub ahead of print]
Khoder WY, Trottmann M, Stuber A, Stief CG, Becker AJ

Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a.
Urol Oncol. 2011; [Epub ahead of print]
May M, Bastian PJ, Brookman-May S, Fritsche HM, Tilki D, Otto W, Bolenz C, Gilfrich C, Trojan L, Herrmann E, Moritz R, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Wieland WF, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Nuhn P, Burger M

Fluorescence-guided laser therapy for penile carcinoma and precancerous lesions: long-term follow-up.
Urol Oncol. 2011;29(6): 788-93
Schlenker B, Gratzke C, Seitz M, Bader MJ, Reich O, Schneede P, Hungerhuber E, Stief CG, Tilki D

Intermediate-differentiated invasive (pT1 G2) penile cancer--oncological outcome and follow-up.
Urol Oncol. 2011;29(6): 782-7
Schlenker B, Tilki D, Gratzke C, Seitz M, Reich O, Schneede P, Stief CG, Hungerhuber E

Contrast-enhanced transrectal ultrasound (CE-TRUS) with cadence-contrast pulse sequence (CPS) technology for the identification of prostate cancer.
Urol Oncol. 2011;29(3): 295-301
Seitz M, Gratzke C, Schlenker B, Buchner A, Karl A, Roosen A, Singer BB, Bastian PJ, Ergün S, Stief CG, Reich O, Tilki D

Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series.
Urol Oncol. 2011;29(5): 508-14
Tilki D, Schlenker B, John M, Buchner A, Stanislaus P, Gratzke C, Karl A, Tan GY, Ergün S, Tewari AK, Stief CG, Seitz M, Reich O

The role of cell-free circulating DNA in the diagnosis and prognosis of prostate cancer.
Urol Oncol. 2011;29(2): 124-9
Ellinger J, Müller SC, Stadler TC, Jung A, von Ruecker A, Bastian PJ

Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder.
Urol Oncol. 2011; [Epub ahead of print]
Kassouf W, Svatek RS, Shariat SF, Novara G, Lerner SP, Fradet Y, Bastian PJ, Aprikian A, Karakiewicz PI, Fritsche HM, Dinney CP, Tilki D, Kamat AM, Izawa JI, Ficarra V, Lotan Y, Sagalowsky AI, Schoenberg MP, Skinner EC

Safety and feasibility of image-guided robotic radiosurgery for patients with limited bone metastases of prostate cancer.
Urol Oncol. 2011; [Epub ahead of print]
Muacevic A, Kufeld M, Rist C, Wowra B, Stief C, Staehler M

[Prolapse surgery : Vaginal mesh or sacropexy.]
Urologe A. 2011;50(7): 798-801
Hamann MF, Bauer RM

[Fast track approach in radical cystectomy].
Urologe A. 2011;50(9): 1072-5
Karl A, Seitz M, Staehler M, Becker A, Weninger E, Rittler P, Stief C

[Oncological and functional results of open intrafascial radical prostatectomy.]
Urologe A. 2011; [Epub ahead of print]
Khoder WY, Buchner A, Siegert S, Stief CG, Schlenker B

[Validation of pre-cystectomy nomograms for the prediction of locally advanced urothelial bladder cancer in a multicentre study : Are we able to adequately predict locally advanced tumour stages before surgery?]
Urologe A. 2011; [Epub ahead of print]
May M, Burger M, Brookman-May S, Otto W, Peter J, Rud O, Fritsche HM, Bolenz C, Trojan L, Herrmann E, Michel MS, Wülfing C, Moritz R, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Bretschneider-Ehrenberg P, Müller O, Zacharias M, Gunia S, Bastian PJ

[Influence of older age on survival after radical cystectomy due to urothelial carcinoma of the bladder : Survival analysis of a German multi-centre study after curative treatment of urothelial carcinoma of the bladder.]
Urologe A. 2011; [Epub ahead of print]
May M, Fritsche HM, Gilfrich C, Brookman-May S, Burger M, Otto W, Bolenz C, Trojan L, Herrmann E, Michel MS, Wülfing C, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Müller O, Bretschneider-Ehrenberg P, Zacharias M, Gunia S, Bastian PJ

[Open urethral surgery in women].
Urologe A. 2011;50(4): 493-500
Tritschler S, Roosen A, Bastian PJ, Stief C

[Drug therapy options for oligoasthenoteratozoospermia syndrome].
Urologe A. 2011;50(1): 8-16
Trottmann
M, Köhn FM, Dickmann M, Stief CG, Becker AJ

[Counselling for erectile dysfunction during inpatient rehabilitation after radical prostatectomy].
Urologe A. 2011;50(4): 417-24
Vahlensieck W, Sommer F, Mathers MJ, Gilbert T, Waidelich R

Results of the AdVance transobturator male sling after radical prostatectomy and adjuvant radiotherapy.
Urology. 2011;77(2): 474-9
Bauer RM, Soljanik I, Füllhase C, Buchner A, May F, Stief CG, Gozzi C

Urodynamic parameters after retrourethral transobturator male sling and their influence on outcome.
Urology. 2011;78(3): 708-12
Soljanik I, Becker AJ, Stief CG, Gozzi C, Bauer RM

Alpha1-adrenoceptor signaling in the human prostate involves regulation of p38 mitogen-activated protein kinase.
Urology. 2011;78(4): 969.e7-13
Strittmatter F, Gratzke C, Walther S, Göttinger J, Beckmann C, Roosen A, Schlenker B, Reich O, Stief CG, Hennenberg M

Single-stage dorsal inlay for reconstruction of recurrent peno-glandular stenosis.
World J Urol. 2011; [Epub ahead of print]
Bastian PJ, Mayer M, Tritschler S, Roosen A, Nuhn P, Bauer RM, Gozzi C

Tyrosine kinase expression profile in clear cell renal cell carcinoma.
World J Urol. 2011; [Epub ahead of print]
Behbahani TE, Thierse C, Baumann C, Holl D, Bastian PJ, von Ruecker A, Müller SC, Ellinger J, Hauser S

Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy.
World J Urol. 2011; [Epub ahead of print]
Chromecki TF, Mauermann J, Cha EK, Svatek RS, Fajkovic H, Karakiewicz PI, Lotan Y, Tilki D, Bastian PJ, Volkmer BG, Montorsi F, Kassouf W, Novara G, Fritsche HM, Ficarra V, Stief CG, Dinney CP, Skinner E, Pummer K, Fradet Y, Shariat SF

Anatomical description of the periprostatic nerves in the male rhesus monkey (Macaca mulatta).
World J Urol. 2011;29(3): 375-80
Ganzer R, Neuhaus J, Gratzke C, Blana A, Wieland WF, Stolzenburg JU

Outcome of laser-assisted laparoscopic partial nephrectomy without ischaemia for peripheral renal tumours.
World J Urol. 2011; [Epub ahead of print]
Khoder WY, Sroka R, Siegert S, Stief CG, Becker AJ

Gender-dependent cancer-specific survival following radical cystectomy.
World J Urol. 2011; [Epub ahead of print]
May M, Stief C, Brookman-May S, Otto W, Gilfrich C, Roigas J, Zacharias M, Wieland WF, Fritsche HM, Hofstädter F, Burger M

Novel options for the treatment of castration-resistant prostate cancer.
World J Urol. 2011; [Epub ahead of print]
Ohlmann CH, Merseburger AS, Suttmann H, Schilling D, Trojan L, Kempkensteffen C, Corvin S, Mathers MJ, Bastian PJ

Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma.
World J Urol. 2011;29(4): 481-6
Shariat SF, Favaretto RL, Gupta A, Fritsche HM, Matsumoto K, Kassouf W, Walton TJ, Tritschler S, Baba S, Matsushita K, Bastian PJ, Martínez-Salamanca JI, Seitz C, Pycha A, Otto W, Karakiewicz PI, Ficarra V, Novara G

Staging of muscle-invasive bladder cancer: can computerized tomography help us to decide on local treatment?
World J Urol. 2011; [Epub ahead of print]
Tritschler S, Mosler C, Straub J, Buchner A, Karl A, Graser A, Stief C, Tilki D

No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional study.
World J Urol. 2011; [Epub ahead of print]
Burger M, Shariat SF, Fritsche HM, Martinez-Salamanca JI, Matsumoto K, Chromecki TF, Ficarra V, Kassouf W, Seitz C, Pycha A, Tritschler S, Walton TJ, Novara G

Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy.
World J Urol. 2011;  [Epub ahead of print]
Chromecki TF, Ehdaie B, Novara G, Pummer K, Zigeuner R, Seitz C, Pycha A, Lee RK, Cha EK, Karakiewicz PI, Ng C, Raman JD, Chun FK, Fritsche HM, Matsumoto K, Kassouf W, Walton TJ, Bastian PJ, Martínez-Salamanca JI, Scherr DS, Shariat SF

Beta-arrestin-2 is expressed in human prostate smooth muscle and a binding partner of ?1A-adrenoceptors.
World J Urol. 2011;29(2): 157-63
Hennenberg M, Schlenker B, Roosen A, Strittmatter F, Walther S, Stief C, Gratzke C

Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients.
World J Urol. 2011; [Epub ahead of print]
Otto W, Shariat SF, Fritsche HM, Gupta A, Matsumoto K, Kassouf W, Martignoni G, Walton TJ, Tritschler S, Baba S, Bastian PJ, Martínez-Salamanca JI, Seitz C, Pycha A, Burger M, Karakiewicz PI, Ficarra V, Novara G

A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX®) and interferon-alpha-2a in metastatic renal cell carcinoma patients.
World J Urol. 2011;29(1): 121-6
Siebels M, Rohrmann K, Oberneder R, Stahler M, Haseke N, Beck J, Hofmann R, Kindler M, Kloepfer P, Stief C

Risk factors of treatment failure after retrourethral transobturator male sling.
World J Urol. 2011; [Epub ahead of print]
Soljanik I, Gozzi C, Becker AJ, Stief CG, Bauer RM